Search  in | Advanced
   Print  
Correspondence

This section contains letters that have been sent by AABB on issues of concern to the transfusion medicine and cellular therapies communities. Click on a link below to read the latest correspondence.

Memo to Members Regarding Technical Correction to the Circular of Information for the Use of Human Blood and Blood Components (August 2009) – 12/22/09
AABB Asks Test Manufacturers to Bring Additional HTLV-I/II Tests to the U.S. Market – 8/31/09 (PDF)
Letter to Facilities with ISBT 128 Variance – 7/16/09
Letter to Facilities with ISBT 128 Status Unknown – 7/16/09
Letter from CMS Clarifying MUE Policy – 4/14/09 (PDF)
Letter to HRSA on Specifications for Accreditation of Cord Blood Banks – 4/10/09
Response from the National Quality Forum Regarding the Definition of a Transfusion-Related Event – 3/5/09 (PDF)
Letter to the National Quality Forum Regarding the Definition of a Transfusion-Related Event – 2/12/09
Letter to FDA from the AABB Ad Hoc Task Force to Propose an Alternate Post-Market Study Design for Seven-Day Platelets – 4/28/08
FDA Response to Letter from AABB Bacterial Contamination Standard Task Force to FDA on Approval Strategies for Point-of-Release Testing for Bacterial Contamination – 4/24/08
Letter to the FDA Nominating Industry Representatives to BPAC – 2/28/08
Letter to the FDA on a Draft Template for a Shorter Inter-donation Interval During an Influenza Pandemic – 2/14/08
Follow up to the Letter from AABB Bacterial Contamination Standard Task Force to Gambro BCT and Fenwal in Response to the Discontinuation of the Passport Study – 2/13/08
Letter to FACT Proposing Accreditation Partnership – 2/4/08
Letter from AABB Bacterial Contamination Standard Task Force to Gambro BCT and Fenwal in Response to the Discontinuation of the Passport Study - 1/31/08
Letter from AABB Bacterial Contamination Standard Task Force to FDA on Approval Strategies for Point-of-Release Testing for Bacterial Contamination - 12/26/07
Letter to the AMA on Cord Blood Banking - 11/16/07
Letter to Verax Biomedical, Inc. Regarding the Platelet PGD® Test - 10/3/07 (PDF)
Letter to HHS on the Appointment of the Advisory Council on Blood Stem Cell Transplantation - 10/2/07
Letter to CMS Requesting Proper Categorization of the eBDS Test System - 9/14/07
Letter to FDA in Response to the Report of the Human Tissue Task Force - 7/6/07
Letter and Proposal to FDA on Component Plasma Licensure - 4/10/07
Letter to Facilities Selected for Inclusion in 2007 NBCUS - 3/7/07 (PDF)
Last modified on 12/23/2009 1:56:25 PM
What's New!
AABB Weekly Report - March 5, 2010
Details
National Hemovigilance Program Launches to Track Adverse Events Associated with Blood Transfusion
Details
AABB Statement on XMRV Task Force
Details
Updated Circular of Information for Cellular Therapy Products
Details
Association Bulletin #10-01 - Association Bulletin Listings
Details
Current U.S. Blood Supply is Adequate to Handle Demands Resulting from Earthquake in Haiti
Details
Emerging Infectious Disease Agents
Details
Study Highlights Implications Of Influenza Pandemics On Blood Supplies
Details
Cellular Therapies Subsections
Details
Association Bulletin #09-08 - ISBT 128 Conditional Accreditation Status
Details
AABB Launches Facebook Fan Page
Details